Attention
Share
Treatment of estrogen receptor-positive and HER2-negative breast cancer Everest Palboxen125 Palboxini 125mg21 capsules/box
Price GH￠ 1,317.00
Coupons
More>
Comprehensive Score
5
cumulative comments 0Goods Guarantee 100% authenticity guarantee
Delivery address China
Ship to
FBM products: 7 days without reason return or exchange
False a compensate ten
Sperification
Quantity
Inventory 100
TospinoMall Commitment
TospinoMall guarantees the security of your transaction: we will only allocate funds to the seller after the buyer confirms the receipt of the goods!
Special recommendation
Afrilinker
Enter Store
Favorite Stores
Hot Picks of the Store
Treatment of estrogen receptor-positive and HER2-negative breast cancer
Everest Palboxen125 Palboxini 125mg21 capsules/box
Indications:
125mg*21 tablets/box
1. Combined with letrozole, used to treat patients with postmenopausal ER-positive and HER2-negative progressive metastatic breast cancer: 2. Combined with fulvestrant, used for patients with ER-positive and HER2-negative breast cancer progressive after endocrine therapy: {For reference only, follow the doctor's advice} The recommended starting dose is once a day, 125 mg each time; used in combination with letrozole, taken with meals for a total of 21 days, and then stop taking the medication for 7 days.
Breast cancer
FDA approval
Authoritative certification
